CEP-33779 CAS:1257704-57-6

CEP-33779 is a highly selective,orally active,small-molecule inhibitor of JAK2. CEP-33779 induced regression of established colorectal tumors,rRadotinib educed angiogenesis,and reduced proliferation of tumor cells.Tumor regression correlated with inhibition of STAT3 and NF-κB(RelA/p65)activation in a CEP-33779 dose-dependent manner.The ability of CEP-33779 to suppress growth of colorectal tumors by inhibiting the IL-6/JAK2/STAT3 signaling suggests a potential therapeutic utility of JAK2 inhibitors in multiple tumors types, particularly those with a strong inflammatory component.

msds----CEP-33779